Literature DB >> 22853317

Antimetastatic effect of nobiletin through the down-regulation of CXC chemokine receptor type 4 and matrix metallopeptidase-9.

Seung Ho Baek1, Sung-Moo Kim, Dongwoo Nam, Jun-Hee Lee, Kyoo Seok Ahn, Seung-Hoon Choi, Sung-Hoon Kim, Bum Sang Shim, Il-Moo Chang, Kwang Seok Ahn.   

Abstract

CONTEXT: Nobiletin is one of the citrus bioflavonoids and can be found in citrus fruits such as lemons, oranges, tangerines, and grapefruits. The most studied properties of nobiletin are its anti-inflammatory and anticancer activities.
OBJECTIVE: The exact mechanisms of how nobiletin inhibits tumor metastasis and invasion are still not fully understood. In this study, we screened various natural compounds to down-modulate the CXC chemokine receptor-4 (CXCR4) and matrix metallopeptidase-9 (MMP-9).
MATERIALS AND METHODS: The effect of nobiletin on the constitutive expressions of CXCR4 and MMP-9, MMP-9 enzymatic activity, associated nuclear factor κB (NF-κB) and mitogen-activated protein kinases (MAPKs) activation, and tumor cell invasion in human breast cancer cells was investigated. CXCR4 and MMP-9 expression were evaluated via reverse transcription polymerase chain reaction (RT-PCR) and western blotting. NF-κB activation was also evaluated by electrophoretic mobility shift assay (EMSA). In addition, the antimetastatic effects of nobiletin were determined by gelatin zymography and invasion assay.
RESULTS: Nobiletin down-regulated both the constitutive expressions of CXCR4 and MMP-9 in human breast cancer cells with IC(50) values of 32 and 24 µM, respectively. Nobiletin also suppressed MMP-9 enzymatic activity and tumor cell invasion under noncytotoxic concentrations. Neither proteasome inhibition nor lysosomal stabilization had any effect on the nobiletin-induced decrease in CXCR4 expression. A detailed study of the underlying molecular mechanisms revealed that the regulation of the down-regulation of CXCR4 and MMP-9 were at the transcriptional level, as indicated by the down-regulation of mRNA expression and the suppression of the constitutive NF-κB and MAPKs activation. DISCUSSION AND
CONCLUSION: Our results indicate, for the first time, that nobiletin is a novel blocker of CXCR4 and MMP-9 expressions and thus has the potential to suppress metastasis of breast cancer.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22853317     DOI: 10.3109/13880209.2012.664151

Source DB:  PubMed          Journal:  Pharm Biol        ISSN: 1388-0209            Impact factor:   3.503


  14 in total

1.  Cisplatin targets the stromal cell-derived factor-1-CXC chemokine receptor type 4 axis to suppress metastasis and invasion of ovarian cancer-initiating cells.

Authors:  Zhi-hua Yu; Te Liu; Yan-hui Zhao; Yong-yi Huang; Yong-tao Gao
Journal:  Tumour Biol       Date:  2014-01-10

2.  Effect of natural flavonoids, stilbenes and caffeic acid oligomers on protein glycation.

Authors:  Kenroh Sasaki; Syuko Chiba; Fumihiko Yoshizaki
Journal:  Biomed Rep       Date:  2014-06-25

3.  Ougan (Citrus reticulata cv. Suavissima) flavedo extract suppresses cancer motility by interfering with epithelial-to-mesenchymal transition in SKOV3 cells.

Authors:  Linlin Chang; Sheng Jia; Yingying Fu; Tianyi Zhou; Ji Cao; Qiaojun He; Bo Yang; Xian Li; Chongde Sun; Dan Su; Hong Zhu; Kunsong Chen
Journal:  Chin Med       Date:  2015-06-27       Impact factor: 5.455

4.  The citrus flavone nobiletin reduces pro-inflammatory and pro-labour mediators in fetal membranes and myometrium: implications for preterm birth.

Authors:  Carrington J Morwood; Martha Lappas
Journal:  PLoS One       Date:  2014-09-19       Impact factor: 3.240

Review 5.  The Multifunctional Effects of Nobiletin and Its Metabolites In Vivo and In Vitro.

Authors:  Hao Huang; Linfu Li; Weimei Shi; Hai Liu; Jianqiong Yang; Xiaoliang Yuan; Longhuo Wu
Journal:  Evid Based Complement Alternat Med       Date:  2016-09-27       Impact factor: 2.629

Review 6.  Chemopreventive Agents and Inhibitors of Cancer Hallmarks: May Citrus Offer New Perspectives?

Authors:  Santa Cirmi; Nadia Ferlazzo; Giovanni E Lombardo; Alessandro Maugeri; Gioacchino Calapai; Sebastiano Gangemi; Michele Navarra
Journal:  Nutrients       Date:  2016-11-04       Impact factor: 5.717

7.  5,6,7,3',4',5'-Hexamethoxyflavone inhibits growth of triple-negative breast cancer cells via suppression of MAPK and Akt signaling pathways and arresting cell cycle.

Authors:  Natasha Borah; Shimara Gunawardana; Haydee Torres; Susan McDonnell; Severine Van Slambrouck
Journal:  Int J Oncol       Date:  2017-10-13       Impact factor: 5.650

Review 8.  The Application of Citrus folium in Breast Cancer and the Mechanism of Its Main Component Nobiletin: A Systematic Review.

Authors:  Yuan Wu; Chien-Shan Cheng; Qiong Li; Jing-Xian Chen; Ling-Ling Lv; Jia-Yue Xu; Kai-Yuan Zhang; Lan Zheng
Journal:  Evid Based Complement Alternat Med       Date:  2021-06-29       Impact factor: 2.629

Review 9.  CXC and CC chemokines as angiogenic modulators in nonhaematological tumors.

Authors:  Matteo Santoni; Sergio Bracarda; Massimo Nabissi; Francesco Massari; Alessandro Conti; Emilio Bria; Giampaolo Tortora; Giorgio Santoni; Stefano Cascinu
Journal:  Biomed Res Int       Date:  2014-05-29       Impact factor: 3.411

10.  Nobiletin inhibits human osteosarcoma cells metastasis by blocking ERK and JNK-mediated MMPs expression.

Authors:  Hsin-Lin Cheng; Ming-Ju Hsieh; Jia-Sin Yang; Chiao-Wen Lin; Ko-Haung Lue; Ko-Hsiu Lu; Shun-Fa Yang
Journal:  Oncotarget       Date:  2016-06-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.